nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Carboplatin—bone cancer	0.164	0.335	CbGbCtD
Clofarabine—ABCG2—Cisplatin—bone cancer	0.14	0.287	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—bone cancer	0.0939	0.192	CbGbCtD
Clofarabine—ABCG2—Methotrexate—bone cancer	0.091	0.186	CbGbCtD
Clofarabine—DCK—Pyrimidine metabolism—NT5C3A—bone cancer	0.0128	0.0551	CbGpPWpGaD
Clofarabine—POLA1—Leading Strand Synthesis—RFC1—bone cancer	0.00944	0.0407	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide Metabolism—DHFR—bone cancer	0.00814	0.0351	CbGpPWpGaD
Clofarabine—RRM2—G1/S-Specific Transcription—DHFR—bone cancer	0.00733	0.0316	CbGpPWpGaD
Clofarabine—POLA1—Lagging Strand Synthesis—RFC1—bone cancer	0.00683	0.0294	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.00674	0.0291	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide Metabolism—DHFR—bone cancer	0.0067	0.0289	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—NT5C3A—bone cancer	0.00647	0.0279	CbGpPWpGaD
Clofarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.00635	0.0273	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—NT5C3A—bone cancer	0.00533	0.023	CbGpPWpGaD
Clofarabine—POLA1—Extension of Telomeres—RFC1—bone cancer	0.00527	0.0227	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—DHFR—bone cancer	0.00523	0.0226	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—DHFR—bone cancer	0.00501	0.0216	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—NT5C3A—bone cancer	0.00498	0.0215	CbGpPWpGaD
Clofarabine—POLA1—DNA strand elongation—RFC1—bone cancer	0.00487	0.021	CbGpPWpGaD
Clofarabine—POLA1—Nucleotide Metabolism—DHFR—bone cancer	0.00458	0.0198	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—DHFR—bone cancer	0.00431	0.0186	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—DHFR—bone cancer	0.00431	0.0186	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00397	0.0171	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—RFC1—bone cancer	0.00392	0.0169	CbGpPWpGaD
Clofarabine—POLA1—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—bone cancer	0.00302	0.013	CbGpPWpGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—bone cancer	0.00299	0.519	CbGdCrCtD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—DHFR—bone cancer	0.00295	0.0127	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—DHFR—bone cancer	0.00277	0.0119	CbGpPWpGaD
Clofarabine—DCK—Epirubicin—Doxorubicin—bone cancer	0.00276	0.481	CbGdCrCtD
Clofarabine—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.00271	0.0117	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00241	0.0104	CbGpPWpGaD
Clofarabine—POLA1—Telomere Maintenance—RFC1—bone cancer	0.00239	0.0103	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—DHFR—bone cancer	0.00228	0.00984	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—RFC1—bone cancer	0.00202	0.00872	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—RFC1—bone cancer	0.00199	0.00858	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00198	0.00855	CbGpPWpGaD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—RB1—bone cancer	0.00197	0.00848	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—RFC1—bone cancer	0.0019	0.00818	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00185	0.00799	CbGpPWpGaD
Clofarabine—POLA1—S Phase—RFC1—bone cancer	0.00166	0.00715	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—DHFR—bone cancer	0.00166	0.00714	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.00161	0.00695	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—DHFR—bone cancer	0.00156	0.00673	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00154	0.00665	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—PLAU—bone cancer	0.00154	0.00664	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—DHFR—bone cancer	0.0014	0.00602	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00136	0.00585	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—RB1—bone cancer	0.00135	0.0058	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00131	0.00566	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—PLAU—bone cancer	0.00127	0.00547	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—RB1—bone cancer	0.00127	0.00546	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.00127	0.00546	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—ZW10—bone cancer	0.0012	0.00518	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.0012	0.00515	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—bone cancer	0.00117	0.00504	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—DHFR—bone cancer	0.00113	0.00488	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.0011	0.00474	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—ZW10—bone cancer	0.0011	0.00474	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00109	0.00469	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—ZW10—bone cancer	0.00107	0.00463	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00107	0.00463	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—RB1—bone cancer	0.00104	0.00449	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.00104	0.00449	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000974	0.0042	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—bone cancer	0.000963	0.00415	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000955	0.00412	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000938	0.00404	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000911	0.00393	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00091	0.00392	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000906	0.00391	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000869	0.00375	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—PLAU—bone cancer	0.000868	0.00374	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000847	0.00365	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RFC1—bone cancer	0.000826	0.00356	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—ZW10—bone cancer	0.000822	0.00354	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TUBB4B—bone cancer	0.000815	0.00351	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000773	0.00333	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—RB1—bone cancer	0.000757	0.00326	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000739	0.00319	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RFC1—bone cancer	0.000739	0.00318	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—ZW10—bone cancer	0.000735	0.00317	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000733	0.00316	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000722	0.00311	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—RB1—bone cancer	0.000713	0.00307	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000713	0.00307	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NDUFA12—bone cancer	0.000709	0.00306	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000675	0.00291	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000673	0.0029	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—RB1—bone cancer	0.000638	0.00275	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000623	0.00269	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.00062	0.00267	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000613	0.00264	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000605	0.00261	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NT5C3A—bone cancer	0.000588	0.00253	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NDUFA12—bone cancer	0.000584	0.00252	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000581	0.0025	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—RB1—bone cancer	0.000573	0.00247	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RFC1—bone cancer	0.000565	0.00243	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TUBB4B—bone cancer	0.000557	0.0024	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NDUFA12—bone cancer	0.000546	0.00235	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDK4—bone cancer	0.00054	0.00233	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000538	0.00232	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—RB1—bone cancer	0.000537	0.00232	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000529	0.00228	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—RB1—bone cancer	0.000518	0.00223	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000512	0.00221	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—DHFR—bone cancer	0.000512	0.00221	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RFC1—bone cancer	0.000505	0.00218	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000502	0.00216	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.0005	0.00216	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NT5C3A—bone cancer	0.000484	0.00209	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000482	0.00208	CbGpPWpGaD
Clofarabine—Tachycardia—Cisplatin—bone cancer	0.000471	0.00172	CcSEcCtD
Clofarabine—POLA1—S Phase—RB1—bone cancer	0.00047	0.00203	CbGpPWpGaD
Clofarabine—Dehydration—Epirubicin—bone cancer	0.000469	0.00172	CcSEcCtD
Clofarabine—Skin disorder—Cisplatin—bone cancer	0.000469	0.00172	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000466	0.00171	CcSEcCtD
Clofarabine—Pain in extremity—Doxorubicin—bone cancer	0.000466	0.00171	CcSEcCtD
Clofarabine—Hyperhidrosis—Cisplatin—bone cancer	0.000466	0.00171	CcSEcCtD
Clofarabine—Dry skin—Epirubicin—bone cancer	0.000462	0.00169	CcSEcCtD
Clofarabine—Abdominal pain upper—Epirubicin—bone cancer	0.00046	0.00169	CcSEcCtD
Clofarabine—Anorexia—Cisplatin—bone cancer	0.00046	0.00168	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—DHFR—bone cancer	0.000458	0.00197	CbGpPWpGaD
Clofarabine—Pancreatitis—Methotrexate—bone cancer	0.000456	0.00167	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000454	0.00166	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000454	0.00166	CcSEcCtD
Clofarabine—DCK—Metabolism—NT5C3A—bone cancer	0.000452	0.00195	CbGpPWpGaD
Clofarabine—Hypotension—Cisplatin—bone cancer	0.000451	0.00165	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000445	0.00163	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000443	0.00191	CbGpPWpGaD
Clofarabine—Pancytopenia—Methotrexate—bone cancer	0.000442	0.00162	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00044	0.00161	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—bone cancer	0.000437	0.0016	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—RB1—bone cancer	0.000436	0.00188	CbGpPWpGaD
Clofarabine—Influenza—Epirubicin—bone cancer	0.000436	0.0016	CcSEcCtD
Clofarabine—Neutropenia—Methotrexate—bone cancer	0.000435	0.00159	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000435	0.00187	CbGpPWpGaD
Clofarabine—Dehydration—Doxorubicin—bone cancer	0.000434	0.00159	CcSEcCtD
Clofarabine—Paraesthesia—Cisplatin—bone cancer	0.000433	0.00159	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Methotrexate—bone cancer	0.000433	0.00158	CcSEcCtD
Clofarabine—Dyspnoea—Cisplatin—bone cancer	0.00043	0.00158	CcSEcCtD
Clofarabine—Dry skin—Doxorubicin—bone cancer	0.000428	0.00157	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—bone cancer	0.000427	0.00156	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—bone cancer	0.000426	0.00156	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00042	0.00154	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00042	0.00154	CcSEcCtD
Clofarabine—Decreased appetite—Cisplatin—bone cancer	0.000419	0.00154	CcSEcCtD
Clofarabine—Pneumonia—Methotrexate—bone cancer	0.000418	0.00153	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000417	0.00153	CcSEcCtD
Clofarabine—Infestation NOS—Methotrexate—bone cancer	0.000415	0.00152	CcSEcCtD
Clofarabine—Infestation—Methotrexate—bone cancer	0.000415	0.00152	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000414	0.00179	CbGpPWpGaD
Clofarabine—Pancytopenia—Epirubicin—bone cancer	0.000414	0.00152	CcSEcCtD
Clofarabine—Pain—Cisplatin—bone cancer	0.000413	0.00151	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000412	0.00151	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000411	0.00151	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—bone cancer	0.000408	0.00149	CcSEcCtD
Clofarabine—Neutropenia—Epirubicin—bone cancer	0.000407	0.00149	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—bone cancer	0.000405	0.00148	CcSEcCtD
Clofarabine—Stomatitis—Methotrexate—bone cancer	0.000405	0.00148	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—bone cancer	0.000403	0.00148	CcSEcCtD
Clofarabine—Feeling abnormal—Cisplatin—bone cancer	0.000398	0.00146	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—bone cancer	0.000396	0.00145	CcSEcCtD
Clofarabine—Pancreatitis—Doxorubicin—bone cancer	0.000395	0.00145	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—bone cancer	0.000394	0.00144	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—bone cancer	0.000393	0.00144	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—bone cancer	0.000392	0.00143	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—bone cancer	0.000391	0.00143	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—bone cancer	0.000388	0.00142	CcSEcCtD
Clofarabine—Infestation—Epirubicin—bone cancer	0.000388	0.00142	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000385	0.00141	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—bone cancer	0.000383	0.0014	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CHEK2—bone cancer	0.000383	0.00165	CbGpPWpGaD
Clofarabine—Renal failure—Epirubicin—bone cancer	0.000382	0.0014	CcSEcCtD
Clofarabine—Body temperature increased—Cisplatin—bone cancer	0.000381	0.0014	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—bone cancer	0.000381	0.00139	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00038	0.00164	CbGpPWpGaD
Clofarabine—Stomatitis—Epirubicin—bone cancer	0.000379	0.00139	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—bone cancer	0.000379	0.00139	CcSEcCtD
Clofarabine—Neutropenia—Doxorubicin—bone cancer	0.000377	0.00138	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000375	0.00137	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—bone cancer	0.000375	0.00137	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—bone cancer	0.000373	0.00136	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—bone cancer	0.00037	0.00136	CcSEcCtD
Clofarabine—Urinary tract disorder—Methotrexate—bone cancer	0.000368	0.00135	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—bone cancer	0.000367	0.00135	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—bone cancer	0.000366	0.00134	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—bone cancer	0.000365	0.00134	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—bone cancer	0.000365	0.00134	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—bone cancer	0.000364	0.00133	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—bone cancer	0.000362	0.00132	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.00036	0.00155	CbGpPWpGaD
Clofarabine—Infestation—Doxorubicin—bone cancer	0.000359	0.00132	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—bone cancer	0.000359	0.00132	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000356	0.00131	CcSEcCtD
Clofarabine—Hypersensitivity—Cisplatin—bone cancer	0.000355	0.0013	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—bone cancer	0.000353	0.00129	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—bone cancer	0.000352	0.00129	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000352	0.00129	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—bone cancer	0.000351	0.00128	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—bone cancer	0.00035	0.00128	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—bone cancer	0.00035	0.00128	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—DHFR—bone cancer	0.00035	0.00151	CbGpPWpGaD
Clofarabine—Haemorrhage—Epirubicin—bone cancer	0.000349	0.00128	CcSEcCtD
Clofarabine—Asthenia—Cisplatin—bone cancer	0.000346	0.00127	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—bone cancer	0.000346	0.00127	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—bone cancer	0.000344	0.00126	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—bone cancer	0.000344	0.00126	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—bone cancer	0.000343	0.00126	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—bone cancer	0.000343	0.00126	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—bone cancer	0.000342	0.00125	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000342	0.00147	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00034	0.00124	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—bone cancer	0.000339	0.00124	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—bone cancer	0.000338	0.00124	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—bone cancer	0.000337	0.00123	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—bone cancer	0.000337	0.00123	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—bone cancer	0.000336	0.00123	CcSEcCtD
Clofarabine—Chills—Methotrexate—bone cancer	0.000334	0.00122	CcSEcCtD
Clofarabine—Diarrhoea—Cisplatin—bone cancer	0.00033	0.00121	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—bone cancer	0.00033	0.00121	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—bone cancer	0.000329	0.00121	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—bone cancer	0.000326	0.0012	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—bone cancer	0.000324	0.00119	CcSEcCtD
Clofarabine—Erythema—Methotrexate—bone cancer	0.000324	0.00119	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—bone cancer	0.000324	0.00119	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—BRCA2—bone cancer	0.000324	0.0014	CbGpPWpGaD
Clofarabine—Flushing—Epirubicin—bone cancer	0.000324	0.00119	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—bone cancer	0.000324	0.00119	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—bone cancer	0.000323	0.00118	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—bone cancer	0.000319	0.00117	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—bone cancer	0.000318	0.00116	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—bone cancer	0.000317	0.00116	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—bone cancer	0.000316	0.00116	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—bone cancer	0.000316	0.00116	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—bone cancer	0.000315	0.00115	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—bone cancer	0.000314	0.00115	CcSEcCtD
Clofarabine—Back pain—Methotrexate—bone cancer	0.000314	0.00115	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000313	0.00135	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—DHFR—bone cancer	0.000313	0.00135	CbGpPWpGaD
Clofarabine—Chills—Epirubicin—bone cancer	0.000313	0.00115	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—bone cancer	0.000308	0.00113	CcSEcCtD
Clofarabine—Vomiting—Cisplatin—bone cancer	0.000307	0.00112	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—bone cancer	0.000306	0.00112	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—bone cancer	0.000305	0.00112	CcSEcCtD
Clofarabine—Rash—Cisplatin—bone cancer	0.000304	0.00111	CcSEcCtD
Clofarabine—Dermatitis—Cisplatin—bone cancer	0.000304	0.00111	CcSEcCtD
Clofarabine—Erythema—Epirubicin—bone cancer	0.000304	0.00111	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—bone cancer	0.000304	0.00111	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000303	0.00131	CbGpPWpGaD
Clofarabine—Anaemia—Methotrexate—bone cancer	0.0003	0.0011	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—bone cancer	0.000299	0.0011	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—bone cancer	0.000299	0.0011	CcSEcCtD
Clofarabine—Back pain—Epirubicin—bone cancer	0.000294	0.00108	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—bone cancer	0.000293	0.00107	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—bone cancer	0.000291	0.00107	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—bone cancer	0.000291	0.00107	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—bone cancer	0.00029	0.00106	CcSEcCtD
Clofarabine—Chills—Doxorubicin—bone cancer	0.00029	0.00106	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000287	0.00124	CbGpPWpGaD
Clofarabine—Nausea—Cisplatin—bone cancer	0.000287	0.00105	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—bone cancer	0.000285	0.00104	CcSEcCtD
Clofarabine—Cough—Methotrexate—bone cancer	0.000283	0.00104	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—bone cancer	0.000283	0.00104	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000282	0.00121	CbGpPWpGaD
Clofarabine—Erythema—Doxorubicin—bone cancer	0.000281	0.00103	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—bone cancer	0.000281	0.00103	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—bone cancer	0.000281	0.00103	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000279	0.0012	CbGpPWpGaD
Clofarabine—Agitation—Epirubicin—bone cancer	0.000279	0.00102	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—bone cancer	0.000276	0.00101	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—bone cancer	0.000276	0.00101	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000274	0.001	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—bone cancer	0.000272	0.000995	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—bone cancer	0.000272	0.000995	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000272	0.00117	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK4—bone cancer	0.000269	0.00116	CbGpPWpGaD
Clofarabine—Cough—Epirubicin—bone cancer	0.000265	0.00097	CcSEcCtD
Clofarabine—Infection—Methotrexate—bone cancer	0.000263	0.000963	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—bone cancer	0.000262	0.00096	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CHEK2—bone cancer	0.000262	0.00113	CbGpPWpGaD
Clofarabine—Nervous system disorder—Methotrexate—bone cancer	0.00026	0.000951	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—bone cancer	0.00026	0.000951	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—bone cancer	0.000259	0.000949	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—bone cancer	0.000258	0.000947	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—bone cancer	0.000258	0.000947	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—bone cancer	0.000258	0.000945	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—bone cancer	0.000258	0.000943	CcSEcCtD
Clofarabine—RRM1—Metabolism—ENO2—bone cancer	0.000257	0.00111	CbGpPWpGaD
Clofarabine—Skin disorder—Methotrexate—bone cancer	0.000257	0.000942	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000257	0.00094	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—bone cancer	0.000256	0.000937	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—bone cancer	0.000252	0.000924	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—bone cancer	0.000251	0.000921	CcSEcCtD
Clofarabine—Oedema—Epirubicin—bone cancer	0.000248	0.000907	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—bone cancer	0.000247	0.000906	CcSEcCtD
Clofarabine—Infection—Epirubicin—bone cancer	0.000246	0.000901	CcSEcCtD
Clofarabine—Cough—Doxorubicin—bone cancer	0.000245	0.000898	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000245	0.00106	CbGpPWpGaD
Clofarabine—Nervous system disorder—Epirubicin—bone cancer	0.000243	0.00089	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—bone cancer	0.000243	0.000888	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—bone cancer	0.000243	0.000888	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—bone cancer	0.000242	0.000886	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000241	0.00104	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000241	0.000883	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—bone cancer	0.000241	0.000881	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDK4—bone cancer	0.000241	0.00104	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—bone cancer	0.00024	0.000877	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—bone cancer	0.000239	0.000876	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—bone cancer	0.000239	0.000876	CcSEcCtD
Clofarabine—RRM1—Metabolism—DHFR—bone cancer	0.000239	0.00103	CbGpPWpGaD
Clofarabine—Anxiety—Doxorubicin—bone cancer	0.000238	0.000873	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—bone cancer	0.000238	0.000871	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000237	0.00087	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—bone cancer	0.000236	0.000865	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—bone cancer	0.000236	0.000864	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—bone cancer	0.000235	0.000862	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—bone cancer	0.000234	0.00101	CbGpPWpGaD
Clofarabine—Hypotension—Epirubicin—bone cancer	0.000232	0.000848	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—bone cancer	0.00023	0.000843	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—bone cancer	0.000229	0.00084	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000229	0.000837	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—bone cancer	0.000228	0.000836	CcSEcCtD
Clofarabine—Infection—Doxorubicin—bone cancer	0.000228	0.000834	CcSEcCtD
Clofarabine—Pain—Methotrexate—bone cancer	0.000226	0.000829	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000226	0.000827	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—bone cancer	0.000225	0.000823	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—bone cancer	0.000224	0.000822	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—bone cancer	0.000224	0.000819	CcSEcCtD
Clofarabine—RRM1—Metabolism—GNA11—bone cancer	0.000223	0.000962	CbGpPWpGaD
Clofarabine—Skin disorder—Doxorubicin—bone cancer	0.000223	0.000815	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—bone cancer	0.000222	0.000815	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BRCA2—bone cancer	0.000222	0.000956	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—bone cancer	0.000222	0.000812	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—bone cancer	0.000221	0.000809	CcSEcCtD
Clofarabine—Somnolence—Epirubicin—bone cancer	0.00022	0.000807	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—bone cancer	0.000219	0.0008	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NDUFA12—bone cancer	0.000218	0.000942	CbGpPWpGaD
Clofarabine—Feeling abnormal—Methotrexate—bone cancer	0.000218	0.000799	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—bone cancer	0.000216	0.000793	CcSEcCtD
Clofarabine—Decreased appetite—Epirubicin—bone cancer	0.000215	0.000789	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—bone cancer	0.000214	0.000785	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000214	0.000783	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—bone cancer	0.000214	0.000922	CbGpPWpGaD
Clofarabine—Fatigue—Epirubicin—bone cancer	0.000214	0.000782	CcSEcCtD
Clofarabine—RRM2—Metabolism—ENO2—bone cancer	0.000212	0.000914	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—bone cancer	0.000212	0.000776	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—bone cancer	0.000209	0.000766	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—bone cancer	0.000209	0.000766	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—RB1—bone cancer	0.000209	0.000901	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000209	0.000765	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—bone cancer	0.000206	0.000754	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—bone cancer	0.000204	0.000749	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—bone cancer	0.000204	0.000748	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—bone cancer	0.000204	0.000746	CcSEcCtD
Clofarabine—Gastrointestinal pain—Epirubicin—bone cancer	0.000203	0.000742	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP3A4—bone cancer	0.000202	0.000872	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—bone cancer	0.000199	0.00073	CcSEcCtD
Clofarabine—DCK—Metabolism—ENO2—bone cancer	0.000198	0.000854	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000198	0.000725	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—bone cancer	0.000198	0.000724	CcSEcCtD
Clofarabine—RRM2—Metabolism—DHFR—bone cancer	0.000197	0.000848	CbGpPWpGaD
Clofarabine—Pain—Doxorubicin—bone cancer	0.000196	0.000718	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—bone cancer	0.000196	0.000717	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—bone cancer	0.000196	0.000717	CcSEcCtD
Clofarabine—Hypersensitivity—Methotrexate—bone cancer	0.000195	0.000714	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000193	0.00083	CbGpPWpGaD
Clofarabine—Asthenia—Methotrexate—bone cancer	0.00019	0.000696	CcSEcCtD
Clofarabine—Feeling abnormal—Doxorubicin—bone cancer	0.000189	0.000692	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000187	0.000687	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—bone cancer	0.000187	0.000686	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—bone cancer	0.000184	0.000793	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNA11—bone cancer	0.000184	0.000792	CbGpPWpGaD
Clofarabine—DCK—Metabolism—DHFR—bone cancer	0.000184	0.000792	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—bone cancer	0.000183	0.000669	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—bone cancer	0.000181	0.000664	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—bone cancer	0.000181	0.000664	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—bone cancer	0.000181	0.000663	CcSEcCtD
Clofarabine—ABCG2—Metabolism—NT5C3A—bone cancer	0.000181	0.00078	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—bone cancer	0.000178	0.000768	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—bone cancer	0.000178	0.000651	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—bone cancer	0.000175	0.000642	CcSEcCtD
Clofarabine—Dizziness—Methotrexate—bone cancer	0.000175	0.000641	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTP1—bone cancer	0.000173	0.000746	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNA11—bone cancer	0.000172	0.00074	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—bone cancer	0.00017	0.000621	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—bone cancer	0.000169	0.000619	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—bone cancer	0.000168	0.000616	CcSEcCtD
Clofarabine—Rash—Methotrexate—bone cancer	0.000167	0.000611	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—bone cancer	0.000167	0.000611	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP3A4—bone cancer	0.000167	0.000718	CbGpPWpGaD
Clofarabine—Headache—Methotrexate—bone cancer	0.000166	0.000607	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDK4—bone cancer	0.000165	0.000709	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—bone cancer	0.000164	0.000602	CcSEcCtD
Clofarabine—Dizziness—Epirubicin—bone cancer	0.000164	0.0006	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—bone cancer	0.000162	0.000594	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000162	0.000697	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—bone cancer	0.00016	0.000689	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—bone cancer	0.000158	0.000577	CcSEcCtD
Clofarabine—Nausea—Methotrexate—bone cancer	0.000157	0.000576	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—bone cancer	0.000157	0.000574	CcSEcCtD
Clofarabine—Rash—Epirubicin—bone cancer	0.000156	0.000572	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—bone cancer	0.000156	0.000572	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP3A4—bone cancer	0.000156	0.000671	CbGpPWpGaD
Clofarabine—Headache—Epirubicin—bone cancer	0.000155	0.000568	CcSEcCtD
Clofarabine—Dizziness—Doxorubicin—bone cancer	0.000152	0.000555	CcSEcCtD
Clofarabine—Nausea—Epirubicin—bone cancer	0.000147	0.000539	CcSEcCtD
Clofarabine—Vomiting—Doxorubicin—bone cancer	0.000146	0.000534	CcSEcCtD
Clofarabine—Rash—Doxorubicin—bone cancer	0.000145	0.000529	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—bone cancer	0.000144	0.000529	CcSEcCtD
Clofarabine—Headache—Doxorubicin—bone cancer	0.000144	0.000526	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RB1—bone cancer	0.000143	0.000616	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—bone cancer	0.000143	0.000614	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—bone cancer	0.000136	0.000499	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTP1—bone cancer	0.000133	0.000574	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—bone cancer	0.000122	0.000526	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—bone cancer	0.000102	0.000441	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—bone cancer	8.97e-05	0.000386	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ENO2—bone cancer	7.93e-05	0.000342	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—bone cancer	7.39e-05	0.000318	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DHFR—bone cancer	7.36e-05	0.000317	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—bone cancer	7e-05	0.000302	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—bone cancer	6.9e-05	0.000297	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNA11—bone cancer	6.88e-05	0.000296	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP3A4—bone cancer	6.23e-05	0.000269	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—bone cancer	5.33e-05	0.00023	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—bone cancer	2.76e-05	0.000119	CbGpPWpGaD
